| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | CBO & EVP | Common Stock | 264,730 | $11,362,212 | $42.92 | 03 Mar 2025 | Direct |
| Passage BIO, Inc. | Director | Employee Stock Option (right to buy) | 174,139 | 30 Sep 2024 | Direct | ||
| Passage BIO, Inc. | Director | Director Stock Option (right to buy) | 143,789 | 28 May 2025 | Direct | ||
| Ultragenyx Pharmaceutical Inc. | CBO & EVP | Stock Option (Right to Buy) | 31,400 | 01 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PASG | Passage BIO, Inc. | 28 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 19:26 |
| RARE | Ultragenyx Pharmaceutical Inc. | 01 Mar 2025 | 3 | -$275,582 | 4 | CBO & EVP | 04 Mar 2025, 20:19 |
| PASG | Passage BIO, Inc. | 30 Sep 2024 | 1 | $0 | 4 | Director | 02 Oct 2024, 16:35 |
| PASG | Passage BIO, Inc. | 10 Sep 2024 | 0 | $0 | 3 | Director | 02 Oct 2024, 16:33 |
| RARE | Ultragenyx Pharmaceutical Inc. | 11 Mar 2024 | 1 | -$574,644 | 4 | CBO & EVP | 12 Mar 2024, 13:41 |
| RARE | Ultragenyx Pharmaceutical Inc. | 01 Mar 2024 | 5 | -$69,062 | 4 | CBO & EVP | 05 Mar 2024, 20:19 |
| RARE | Ultragenyx Pharmaceutical Inc. | 23 Oct 2023 | 3 | -$1,033,638 | 4 | CBO & EVP | 24 Oct 2023, 17:22 |
| RARE | Ultragenyx Pharmaceutical Inc. | 01 Mar 2023 | 5 | -$244,027 | 4 | CBO & EVP | 03 Mar 2023, 18:57 |
| RARE | Ultragenyx Pharmaceutical Inc. | 11 Mar 2022 | 1 | -$688,930 | 4 | CBO & EVP | 15 Mar 2022, 16:33 |
| RARE | Ultragenyx Pharmaceutical Inc. | 01 Mar 2022 | 3 | -$158,156 | 4 | CBO & EVP | 03 Mar 2022, 17:07 |
| RARE | Ultragenyx Pharmaceutical Inc. | 31 Dec 2021 | 1 | $0 | 5 | CBO & EVP | 01 Feb 2022, 12:42 |
| RARE | Ultragenyx Pharmaceutical Inc. | 14 Oct 2021 | 1 | -$23,206 | 4 | CBO & EVP | 18 Oct 2021, 18:48 |
| RARE | Ultragenyx Pharmaceutical Inc. | 30 Sep 2021 | 2 | +$34,018 | 4 | CBO & EVP | 01 Oct 2021, 12:57 |
| RARE | Ultragenyx Pharmaceutical Inc. | 06 May 2021 | 1 | -$41,269 | 4 | CBO & EVP | 10 May 2021, 18:11 |